D-dimers and ferritin: Expanding the diagnostic panel for cirrhotic ascites evaluation

1 Runyon BA; AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013 Apr;57(4):1651-3. DOI: 10.1002/hep.26359 Search in Google Scholar

2 Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut. 2006;55 Suppl 6(Suppl 6):vi1-2. DOI: 10.1136/gut.2006.099580 Search in Google Scholar

3 Runyon BA. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology. 1986 Dec;91(6):1343-6. DOI: 10.1016/0016-5085(86)90185-X Search in Google Scholar

4 Plessier A, Denninger MH, Consigny Y, Pessione F, Francoz C, Durand F, et al. Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int. 2003 Dec;23(6):440-8. DOI: 10.1111/j.1478-3231.2003.00870.x Search in Google Scholar

5 Trifonov P, Ivanova I, Papochiev K, Robev B, Nikolov R, Krastev Z. The D- Dimer and Ferritin Silent Life in Ascites: A Pilot Study. Medinform 2023; 10(1):1677-85. DOI: 10.18044/MedInform.2023101.1677 Search in Google Scholar

6 Hu KQ, Yu AS, Tiyyagura L, Redeker AG, Reynolds TB. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit. Am J Gastroenterol. 2001 May;96(5):1581-6. DOI: 10.1111/j.1572-0241.2001.03781.x Search in Google Scholar

7 Saray A, Mesihovic R, Gornjakovic S, Vanis N, Mehmedovic A, Nahodovic K, et al. Association between high D-dimer plasma levels and ascites in patients with liver cirrhosis. Med Arch. 2012;66(6):372-4. DOI: 10.5455/medarh.2012.66.372-374 Search in Google Scholar

8 Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol. 2000 Nov;95(11):3218-24. DOI: 10.1111/j.1572-0241.2000.03299.x Search in Google Scholar

9 Toschi V, Rocchini GM, Motta A, Fiorini GF, Cimminiello C, Violi F, et al. The hyperfibrinolytic state of liver cirrhosis: possible pathogenetic role of ascites. Biomed Pharmacother. 1993;47(8):345-52. DOI: 10.1016/0753-3322(93)90084-X Search in Google Scholar

10 Kogan AE, Mukharyamova KS, Bereznikova AV, Filatov VL, Koshkina EV, Bloshchitsyna MN, et al. Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products. Blood Coagul Fibrinolysis. 2016 Jul;27(5):542-50. DOI: 10.1097/MBC.0000000000000453 Search in Google Scholar

11 Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016 Jul 15;9:229-55. DOI: 10.2147/IJGM.S102819 Search in Google Scholar

12 Johnson CA, Sobrinho TC, Aziz EM, Rogers SB. Refractory coagulopathy in an infant with loss of clotting proteins into ascitic fluid. Acta Paediatr Scand. 1976 Nov;65(6):773-5. DOI: 10.1111/j.1651-2227.1976.tb18019.x Search in Google Scholar

13 El Gohary AM, Elyamany AS, Mikhael NL, Mahmoud MG, Tawfik MMR. Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis. Clin Exp Hepatol. 2021 Jun;7(2):134-140. DOI: 10.5114/ceh.2021.105915 Search in Google Scholar

14 Romanelli R, Cellai A, Lami D,Natucci F, Tosti-Guerra C, Abbate R, et al. D-dimer and fibrinolytic activity in patients with decompensated liver cirrhosis. Digest Liver Dis 2015;47:e33. DOI: 10.1016/j.dld.2015.01.073 Search in Google Scholar

15 Takatori M, Iwabuchi S, Hayashi T, Teramoto T, Tanaka Y,Yoshida Y, et al. Comparative study for coagulation-fibrinolysis parameters between in ascitic fluid and plasma in patients with decompensated liver cirrhosis. Japan J Thromb Hemostasis 1992;3:238-42. DOI: 10.2491/jjsth.3.238 Search in Google Scholar

16 Hoefs J, Barnes T, Halle P. Intraperitoneal coagulation in chronic liver disease ascites. Digestive Diseases and Sciences 1981, 26(6), 518-22. DOI: 10.1007/BF01308100 Search in Google Scholar

17 Kountouras J, Boura P, Tsapas G, Charisis K, Magoula I, Tsakiri I. Value of ascitic fluid ferritin in the differential diagnosis of malignant ascites. Anticancer Research. 1993 Nov-Dec;13(6B):2441-5. Search in Google Scholar

18 Savaş MC, Abdurrahman K, Halis Ş, Kadri M. Ferritin levels in cirrhotic and malignant ascites. Turkiye Klinikleri J Med Res. 1994;12(6):236-8. Search in Google Scholar

19 Chiou B, Connor JR. Emerging and Dynamic Biomedical Uses of Ferritin. Pharmaceuticals (Basel). 2018;11(4):124. DOI: 10.3390/ph11040124 Search in Google Scholar